GeoVax Labs (GOVX) Proxy Filing summary

Executive summary

• Special Meeting of Stockholders scheduled for September 17, 2024, to vote on two key proposals related to the issuance of common stock upon exercise of warrants issued in May and July 2024 private placements.

• Both proposals seek approval under Nasdaq listing rules to issue shares exceeding 20% of outstanding common stock, potentially impacting control and dilution.

• Board of Directors unanimously recommends voting in favor of both proposals.

Voting matters and shareholder proposals

• Proposal 1: Approve issuance of up to 1,605,688 shares upon exercise of the May 2024 Warrant at $1.68 per share, expiring May 21, 2029.

• Proposal 2: Approve issuance of up to 2,170,000 shares upon exercise of the July 2024 Warrant at $2.86 per share, expiring five years from shareholder approval.

• Both proposals require a majority of votes cast for approval; abstentions count as votes against, broker non-votes have no effect.

• Failure to approve would limit the company’s ability to issue shares above the exchange cap and require repeated shareholder meetings.

Board of directors and corporate governance

• Board fixed July 22, 2024, as the record date for voting eligibility.

• Board members and officers may solicit proxies without additional compensation; company may engage third-party proxy solicitors at its expense.